University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2017–2022 · research · R01

Macrophage development and specification in mice.

Frederic Geissmann · Kettering University · funded by National Institutes of Health

$579.1k

2017–2020 · research · R21

Imaging the efficacy of TRAIL-enhanced cancer immunotherapy

Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health

$187.9kCAR-T cell therapy research

2017–2021 · research · R01

Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood

Michael Kharas · Kettering University · funded by National Institutes of Health

$698.6kMicroRNA in disease regulation

2017–2022 · cooperative agreement · U01

Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome

Richard N Kolesnick · Kettering University · funded by National Institutes of Health

$583.8kSphingolipid Metabolism and Signaling

2017–2020 · research · R00

Investigating cellular heterogeneity in lung cancer

Tuomas Tammela · Kettering University · funded by National Institutes of Health

$258.8kCancer Cells and Metastasis

2017–2022 · research · R01

A Single-Molecule Study of Translation Initiation in S. cerevisiae

Xiaohui Qu · Kettering University · funded by National Institutes of Health

$422.1kRNA and protein synthesis mechanisms

2017–2027 · research · R01

Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions

Gretchen E Diehl · Kettering University · funded by National Institutes of Health

$531k

2017–2022 · research · R25

Tobacco Treatment Training for Cancer Care Providers

Jamie S. Ostroff · Kettering University · funded by National Institutes of Health

$252kSmoking Behavior and Cessation

2017–2022 · research · R01

Programming age in iPS models of Alzheimer's disease

Lorenz P. Studer · Kettering University · funded by National Institutes of Health

$449k

2017–2022 · cooperative agreement · U24

Coordinating center for the NCI small cell lung cancer research consortium

Charles M. Rudin · Kettering University · funded by National Institutes of Health

$1.3MLung Cancer Research Studies

2017–2022 · research · R01

Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases

Doron Betel · Kettering University · funded by National Institutes of Health

$562kPluripotent Stem Cells Research

2017–2022 · cooperative agreement · U24

The cBioPortal for Cancer Genomics

Ethan Cerami · Kettering University · funded by National Institutes of Health

$1.2M

2017–2024 · research · R35

Isolation, characterization and translational development of glioma stem cells

Luis Fernando Parada · Kettering University · funded by National Institutes of Health

$1M

2017–2019 · fellowship · F31

CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells

Nicholas F Kuhn · Kettering University · funded by National Institutes of Health

$32.6kCAR-T cell therapy research

2017–2022 · research · R01

The role of reorganization energy in achieving selective kinase inhibition"

John Damon Chodera · Kettering University · funded by National Institutes of Health

$99.7k

2017–2022 · research · R01

Schwann Cell Reprogramming and Cancer Perineural Invasion

Richard J Wong · Kettering University · funded by National Institutes of Health

$628.1kCancer, Stress, Anesthesia, and Immune Response

2017–2021 · research · R01

Sizing and Scaling in Functional Muscle Cells

Mary K Baylies · Kettering University · funded by National Institutes of Health

$463kMuscle Physiology and Disorders

2017–2019 · fellowship · F32

The role of adipocytes in melanoma

Xiang Zhang · Kettering University · funded by National Institutes of Health

$57.1k

2017–2022 · cooperative agreement · U54

The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center

Charles L. Sawyers · Kettering University · funded by National Institutes of Health

$1.3M

2017–2022 · cooperative agreement · U01

Quantitative imaging tools to derive DW-MRI oncological biomarkers

Amita Dave · Kettering University · funded by National Institutes of Health

$669.6kMRI in cancer diagnosis

2017–2022 · research · R01

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

Paul Tempst · Kettering University · funded by National Institutes of Health

$614.3k

2017–2019 · research · R21

Imaging VEGFR-1 in early metastatic lesions

Joseph M Backer · Kettering University · funded by National Institutes of Health

$229.4kAngiogenesis and VEGF in Cancer

2017–2022 · cooperative agreement · U01

Quantitative imaging tools to derive DW-MRI oncological biomarkers

Amita Dave · Kettering University · funded by National Institutes of Health

$681.8kMRI in cancer diagnosis

2017–2022 · research · R01

Ferroptosis, Cellular Metabolism, and Cancer

Xuejun Jiang · Kettering University · funded by National Institutes of Health

$415.2kFerroptosis and cancer prognosis

2017–2022 · research · R01

Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases

Doron Betel · Kettering University · funded by National Institutes of Health

$568.5kPluripotent Stem Cells Research

2017–2022 · research · R01

Imaging tumor and T cell responses to metabolic and immune modulation therapy

Ronald George Blasberg · Kettering University · funded by National Institutes of Health

$713kCancer Immunotherapy and Biomarkers

2017–2021 · cooperative agreement · U01

Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D

Christina S Leslie · Kettering University · funded by National Institutes of Health

$717.3kGenomics and Chromatin Dynamics

2017–2022 · research · R01

The role of reorganization energy in achieving selective kinase inhibition

John Damon Chodera · Kettering University · funded by National Institutes of Health

$337k

2017–2022 · research · R25

Tobacco Treatment Training for Cancer Care Providers

Jamie S. Ostroff · Kettering University · funded by National Institutes of Health

$260.8kSmoking Behavior and Cessation

2017–2021 · fellowship · F31

CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells

Nicholas F Kuhn · Kettering University · funded by National Institutes of Health

$44kCAR-T cell therapy research

2017–2021 · fellowship · F31

Investigating Bruton's Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma

Sarah Tang · Kettering University · funded by National Institutes of Health

$44.5kCNS Lymphoma Diagnosis and Treatment

2017–2022 · research · R01

Understanding Long Tail Driver Mutations in Cancer

Nikolaus Schultz · Kettering University · funded by National Institutes of Health

$410.8kCancer Genomics and Diagnostics

2017–2021 · research · R01

Therapeutic approaches to ER mutant breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$392.1kEstrogen and related hormone effects

2017–2021 · research · R01

Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)

Ping Chi · Kettering University · funded by U.S. Food and Drug Administration

$500k

2017–2022 · research · R01

Smart and self-reporting clinical nano carriers for drug delivery

Jan Grimm · Kettering University · funded by National Institutes of Health

$697.8kNanoparticle-Based Drug Delivery

2017–2022 · career development · K23

Enhancing Understanding of Harms and Benefits of Cardiac Monitoring During Breast Cancer Therapy

Anthony Francis Yu · Kettering University · funded by National Institutes of Health

$176.8kChemotherapy-induced cardiotoxicity and mitigation

2017–2022 · research · R01

Macrophage development and specification in mice.

Frederic Geissmann · Kettering University · funded by National Institutes of Health

$579.1k

2017–2023 · research · R35

Synergistic role of signaling and epigenetics in leukemic transformation

Ross L Levine · Kettering University · funded by National Institutes of Health

$932.5kAcute Myeloid Leukemia Research

2017–2030 · research · R35

Synergistic role of signaling and epigenetics in leukemic transformation

Ross L Levine · Kettering University · funded by National Institutes of Health

$1.1M

2017–2021 · research · R01

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody

Jason S. Lewis · Kettering University · funded by National Institutes of Health

$446.7kLung Cancer Research Studies